Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection

Clicks: 388
ID: 116723
2007
Empirical use of beta-lactam antibiotics, the preferred agents for treating uncomplicated skin and soft tissue infections, may no longer be appropriate for these infections because of the increasing prevalence of community strains of methicillin-resistant Staphylococcus aureus (MRSA). Retrospective …
Reference Key
pm2007antimicrobialrandomized, Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rajendran PM;Young D;Maurer T;Chambers H;Perdreau-Remington F;Ro P;Harris H;;
Journal Antimicrobial agents and chemotherapy
Year 2007
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/17846141
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome research support non-u.s. gov't u.s. gov't adult female male N.I.H. Extramural aged middle aged P.H.S. Randomized Controlled Trial Double-Blind Method anti-bacterial agents / therapeutic use community-acquired infections / microbiology methicillin resistance* microbial sensitivity tests staphylococcus aureus / drug effects* community-acquired infections / drug therapy* staphylococcal infections / drug therapy* staphylococcal skin infections / drug therapy community-acquired infections / pathology pmid:17846141 pmc2151464 doi:10.1128/aac.00377-07 priya m rajendran david young hobart harris abscess / drug therapy abscess / pathology cephalexin / therapeutic use* staphylococcal infections / pathology staphylococcal skin infections / pathology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.